Anti-TNF Antibody Therapy for Inflammatory Bowel Disease During Pregnancy: A Clinical Review

E-ISSN： 1873-5592|11|2|234-241

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.2, 2010-02, pp. : 234-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How to Manage the Infectious Risk under Anti-TNF in Inflammatory Bowel Disease

Current Drug Targets, Vol. 11, Iss. 2, 2010-02 ,pp. : 198-218

Bentham Science Publishers

Access to resources Recommend Favorite

Utility of Measuring Serum Concentrations of Anti-TNF Agents and Anti-Drug Antibodies in Inflammatory Bowel Disease

Current Drug Metabolism, Vol. 12, Iss. 6, 2011-07 ,pp. : 594-598

Bentham Science Publishers

Access to resources Recommend Favorite

Measurement of Anti-TNF Agents and Anti-Drug Antibodies Serum Levels in Patients with Inflammatory Bowel Disease

Current Drug Metabolism, Vol. 15, Iss. 9, 2014-11 ,pp. : 875-881

Bentham Science Publishers

Access to resources Recommend Favorite

Treating Inflammatory Bowel Disease During Pregnancy: Risks and Safety of Drug Therapy

By Connell W. Miller A.

Drug Safety, Vol. 21, Iss. 4, 1999-10 ,pp. : 311-323

Adis International

Access to resources Recommend Favorite

Anti-TNF Antibodies in Inflammatory Bowel Disease: Do We Finally Know How it Works?

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1421-1432

Bentham Science Publishers

Access to resources Recommend Favorite